Sign in to view content

Safety and Efficacy of SC Elamipretide to Treat Noncentral Geographic Atrophy: ReCLAIM-1 Results and Phase II ReCLAIM-2 Baseline Characteristics

David R Lally, MD

Video
Published 2021

Related

Machine Learning Enabled Outer Retinal OCT Biomarker Extraction for Identification of High-Risk AMD Eyes for Subfoveal Geographic Atrophy Progression
Kubra Sarici, MD
Annual Meeting Talks
2021
Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 9: Rate of Macular Atrophy in HARBOR Study with Dr. SriniVas Sadda
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: AMD-Non-Neovascular

See more